Hong Kong will once again take center stage in the global healthcare and biotechnology landscape as it hosts the fifth edition of the Asia Summit On Global Health (ASGH 2025) from May 26th to 27th at the Hong Kong Convention and Exhibition Centre (HKCEC). Organized by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council (HKTDC), 1  this premier event is set to gather leading experts, investors, researchers, and policymakers from around the world to exchange insights on industry trends, policy directions, and foster collaborations. The summit will also feature investment and partnership-focused side events, generating significant anticipation within the global healthcare community.

ASGH: A Hub for Global Healthcare and Biotech Innovation

The ASGH has firmly established itself as Hong Kong's largest and most influential event in the healthcare and biotechnology sectors. This annual summit serves as a vital platform for professionals and government officials to converge, share expertise, and explore potential partnerships.

The previous edition of ASGH in 2024 witnessed an impressive turnout of over 2,800 attendees from 40 countries and regions. The distinguished list of participants included Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO); Mr. John Lee, Chief Executive of the HKSAR; Professor Lo Chung-mau, Secretary for Health of the HKSAR Government; and Mr. Yasunaga Tatsuo, Chairman of Mitsui & Co., Ltd. Renowned healthcare experts such as Dr. Eric Green, Director of the National Human Genome Research Institute (NIH), and Professor Roger Kornberg of Stanford University also graced the event. South Korea was notably represented by Dr. Park Seung-beom, CEO of Spark Biopharma, and Dr. Kim Sang-tae, Head of Informatics and Artificial Intelligence at BERTHiS. The summit facilitated over 360 business matching sessions, underscoring its role in driving tangible collaborations.

This year's ASGH will be held under the theme "Fostering Global Collaboration for a Shared Future," emphasizing the critical need for international cooperation to address pressing healthcare challenges and unlock future opportunities.

Comprehensive Symposium Program Addressing Key Healthcare Trends

ASGH 2025 will feature a comprehensive symposium program encompassing global health and medical advancements, Asian business and investment prospects, and cutting-edge trends in the healthcare and biomedical industries. Key session topics include:

Building Equitable and Sustainable Health Systems: Addressing disparities and ensuring long-term resilience in healthcare delivery.
Navigating the Silver Tsunami: Advances in Geriatrics and Longevity Technologies: Exploring innovations to support aging populations and extend healthy lifespans.
The Patient Experience Revolution: Powered by Digital and Data-Driven Healthcare: Examining how technology is transforming patient care and engagement.
Unlocking the Potential of AI and Robotics in Healthcare: Discussing the transformative applications of artificial intelligence and robotics in diagnosis, treatment, and healthcare management.
Strategic Investment in Healthcare Innovation: Analyzing investment trends and opportunities in emerging healthcare technologies and solutions.
Women's Health: Addressing specific health challenges and advancements in women's healthcare.
New Paradigms in Cancer Therapy: Exploring the latest breakthroughs and innovative approaches in cancer treatment.
The Future of Gene and Cell Therapy: Examining the potential of these advanced therapies for treating a wide range of diseases.
Orphan Drugs and Rare Disease Treatments: Addressing the challenges and opportunities in developing therapies for rare diseases.
Esteemed speakers confirmed for these sessions include Professor Cho Kwang-hyun from KAIST, Mr. Keum Chang-won, CEO of 3billion, Mr. Marc Horn, Executive Vice President of Merck Group and President of Merck China, Professor Karim Asehnoune, Chief Medical Officer of Nantes University Hospital, and Mr. Victor Chu, Chairman of First Eastern Investment Group.

Supporting Innovation and Facilitating Partnerships

Recognizing the crucial role of startups in driving healthcare innovation, ASGH 2025 will feature a dedicated exhibition space called the "InnoHealth Showcase." This platform will provide startups (established within the last eight years) with an opportunity to present their innovative technologies and solutions to a global audience of investors and potential partners.

Furthermore, the summit will offer a "Healthcare Cluster Visit Programme" to Shenzhen, a major healthcare industry hub in mainland China. This program will allow participants to gain firsthand insights into the dynamic healthcare ecosystem in the Greater Bay Area.

A key feature of ASGH is its "Deal-Making" sessions, which will facilitate one-on-one meetings between healthcare companies with innovative technologies and potential investors. This dedicated networking platform aims to foster collaborations and drive investment deals within the industry.

International Healthcare Week: A Comprehensive Showcase of Global Healthcare

Extending beyond the two-day summit, Hong Kong will host the "International Healthcare Week (IHW)" from May 26th to June 15th, organized by the HKTDC. During this period, a series of exhibitions and networking events will take place across Hong Kong, attracting healthcare companies from around the globe.

A significant component of IHW is the "Hong Kong International Medical and Healthcare Fair," scheduled to run from May 26th to 28th. This fair serves as a vital platform for industry players to share the latest research and development findings, connect with potential business partners, and engage with investors. The fair covers a wide spectrum of the healthcare industry, including biotechnology (vaccines, allergy testing), hospital equipment, elderly care, and rehabilitation. The previous edition in 2024 attracted 296 exhibitors from eight countries and regions, including Hong Kong, mainland China, South Korea, Japan, Canada, Hungary, India, and Taiwan, and welcomed over 12,000 buyers from 60 countries and regions.

Hong Kong: A Premier Investment Hub for Global Healthcare

A representative from the HKTDC emphasized Hong Kong's strategic position as a leading investment hub for the global healthcare and biotechnology sectors. "The International Healthcare Week, encompassing ASGH and the Hong Kong International Medical and Healthcare Fair, will underscore Hong Kong's role as a premier R&D collaboration base for leading companies worldwide," the representative stated. The events are expected to further solidify Hong Kong's reputation as a gateway for international healthcare businesses looking to expand into Asia and for Asian companies seeking global partnerships and investments.

By bringing together a diverse range of stakeholders, fostering meaningful dialogues, and facilitating crucial business connections, the Asia Summit On Global Health 2025 and the broader International Healthcare Week are poised to make significant contributions to the advancement of global healthcare and the cultivation of a healthier future for all. The focus on collaboration, innovation, and investment underscores Hong Kong's commitment to driving progress in this vital sector.